Medifast Share Price Today
(NASDAQ: MED)

Name: Medifast Share Price Today (NASDAQ: MED) - Medifast Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Medifast share price is $14.09 & ₹1,225.39 as on 6 Mar 2025, 2.30 'hrs' IST

$14.09

▲

-0.14

(-0.98%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Medifast share price in Dollar and Rupees. Guide to invest in Medifast stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Medifast, along with analyst recommendations, forecasts, and comprehensive financials.

Medifast share price movements

Today's Low: $14.08
Today's High: $14.40
$14.09
0.07%
Downside
Day's Volatility :2.22%
Upside
2.15%
52 Weeks Low: $13.57
52 Weeks High: $40.32
$14.09
3.69%
Downside
52 Weeks Volatility :66.34%
Upside
65.05%

Medifast (MED) Returns

Period	Medifast Inc	Sector (Consumer Staples)	Index (Russel 2000)
3 Months	-29.41%	0.1%	0.0%
6 Months	-26.58%	-0.7%	0.0%
1 Year	-62.96%	9.4%	0.0%
3 Years	-92.05%	8.7%	-11.6%

Medifast (MED) Key Statistics

in dollars & INR

Previous Close	$14.23
Open	$14.23
Today's High	$14.4
Today's Low	$14.08
Market Capitalization	$154.1M
Today's Volume	$161.3K
52 Week High	$40.32
52 Week Low	$13.57
Revenue TTM	$602.5M
EBITDA	$18.9M
Earnings Per Share (EPS)	$0.19
PE Ratio	74.16
Profit Margin	0.35%
Quarterly Earnings Growth YOY	-0.87%
Return On Equity TTM	1.02%

How to invest in Medifast Stock (MED) from India?

It is very easy for Indian residents to invest directly in Medifast from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Medifast stock in both Indian Rupees (INR) and US Dollars (USD). Search for Medifast or MED on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Medifast or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Medifast shares which would translate to 0.062 fractional shares of Medifast as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Medifast, in just a few clicks!

Returns in Medifast (MED) for Indian investors in Rupees

The Medifast stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Medifast investment value today

Current value as on today

₹41,989

Returns

₹58,011

(-58.01%)

Returns from Medifast Stock

₹62,960 (-62.96%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Medifast (MED)

26%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Medifast Stock from India on INDmoney has increased by 26% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Medifast

BlackRock Inc
8.41%
Renaissance Technologies Corp
8.26%
Vanguard Group Inc
6.93%
Goldman Sachs Group Inc
3.23%
Hotchkis & Wiley Capital Management LLC
2.70%
D. E. Shaw & Co LP
2.64%

Analyst Recommendation on Medifast

Sell

0%Buy

44%Hold

55%Sell

Based on 9 Wall street analysts offering stock ratings for Medifast(by analysts ranked 0 to 5 stars)

Based on 9 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Medifast Stock (MED)

What analysts predicted

Upside of 11.78%

Target:

$15.75

Current:

$14.09

Insights on Medifast Stock (Ticker Symbol: MED)

Price Movement
In the last 3 years, MED stock has moved down by -92.4%
Decreasing Revenue
Revenue is down for the last 8 quarters, 348.98M → 119.00M (in $), with an average decrease of 14.1% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, 1.12M → 800.0K (in $), with an average decrease of 29.1% per quarter
MED vs FTDR (1 yr)
In the last 1 year, Frontdoor Inc has given 37.7% return, outperforming this stock by 100.7%
MED vs HRB (3 yr)
In the last 3 years, H&r Block, Inc. has given 41.1% return, outperforming this stock by 133.5%
Price to Sales
ForMED every $1 of sales, investors are willing to pay $0.3, whereas for Frontdoor Inc, the investors are paying $1.8 for every $1 of sales.

MED Medifast Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$713.7M	↑ 42.45%
Net Income	$77.9M	↑ 39.66%
Net Profit Margin	10.92%	↓ 0.22%

	FY20	Y/Y Change
Revenue	$934.8M	↑ 30.99%
Net Income	$102.9M	↑ 32.01%
Net Profit Margin	11.0%	↑ 0.08%

	FY21	Y/Y Change
Revenue	$1.5B	↑ 63.25%
Net Income	$164.0M	↑ 59.47%
Net Profit Margin	10.75%	↓ 0.25%

	FY22	Y/Y Change
Revenue	$1.6B	↑ 4.75%
Net Income	$143.6M	↓ 12.48%
Net Profit Margin	8.98%	↓ 1.77%

	FY23	Y/Y Change
Revenue	$1.1B	↓ 32.94%
Net Income	$99.4M	↓ 30.75%
Net Profit Margin	9.27%	↑ 0.29%

	FY24	Y/Y Change
Revenue	$602.5M	↓ 43.8%
Net Income	$2.1M	↓ 97.9%
Net Profit Margin	0.35%	↓ 8.92%

	Q3 FY23	Q/Q Change
Revenue	$235.9M	↓ 20.37%
Net Income	$23.1M	↓ 23.61%
Net Profit Margin	9.81%	↓ 0.41%

	Q4 FY23	Q/Q Change
Revenue	$191.0M	↓ 19.02%
Net Income	$6.0M	↓ 73.91%
Net Profit Margin	3.16%	↓ 6.65%

	Q1 FY24	Q/Q Change
Revenue	$174.7M	↓ 8.52%
Net Income	$8.3M	↑ 37.8%
Net Profit Margin	4.76%	↑ 1.6%

	Q2 FY24	Q/Q Change
Revenue	$168.6M	↓ 3.54%
Net Income	$-8.2M	↓ 198.05%
Net Profit Margin	-4.84%	↓ 9.6%

	Q3 FY24	Q/Q Change
Revenue	$140.2M	↓ 16.85%
Net Income	$1.1M	↓ 113.85%
Net Profit Margin	0.81%	↑ 5.65%

	Q4 FY24	Q/Q Change
Revenue	$119.0M	↓ 15.1%
Net Income	$800.0K	↓ 29.14%
Net Profit Margin	0.67%	↓ 0.14%

	FY19	Y/Y Change
Profit	$536.9M	↑ 41.32%

	FY20	Y/Y Change
Profit	$697.8M	↑ 29.98%

	FY21	Y/Y Change
Profit	$1.1B	↑ 61.59%

	FY22	Y/Y Change
Profit	$1.1B	↑ 1.14%

	FY23	Y/Y Change
Profit	$775.9M	↓ 31.97%

	FY24	Y/Y Change
Profit	$444.6M	↓ 42.69%

	Q3 FY23	Q/Q Change
Profit	$177.4M	↓ 15.82%

	Q4 FY23	Q/Q Change
Profit	$141.4M	↓ 20.3%

	Q1 FY24	Q/Q Change
Profit	$127.3M	↓ 9.96%

	Q2 FY24	Q/Q Change
Profit	$123.4M	↓ 3.03%

	Q3 FY24	Q/Q Change
Profit	$105.7M	↓ 14.39%

	Q4 FY24	Q/Q Change
Profit	$88.2M	↓ 16.52%

	FY19	Y/Y Change
Operating Cash Flow	$84.3M	↑ 38.55%
Investing Cash Flow	$-6.3M	↑ 427.77%
Financing Cash Flow	$-82.3M	↑ 54.37%

	FY20	Y/Y Change
Operating Cash Flow	$145.2M	↑ 72.32%
Investing Cash Flow	$-1.3M	↓ 79.74%
Financing Cash Flow	$-57.1M	↓ 30.59%

	FY21	Y/Y Change
Operating Cash Flow	$94.5M	↓ 34.88%
Investing Cash Flow	$-29.1M	↑ 2167.08%
Financing Cash Flow	$-125.1M	↑ 118.98%

	FY22	Y/Y Change
Operating Cash Flow	$194.6M	↑ 105.8%
Investing Cash Flow	$-11.4M	↓ 60.73%
Financing Cash Flow	$-199.6M	↑ 59.5%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$29.9M	↓ 30.63%
Investing Cash Flow	$-50.3M	↑ 2785.09%
Financing Cash Flow	$-18.2M	↑ 1.78%

Medifast Technicals Summary

Sell

Neutral

Buy

Medifast is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Medifast (MED) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Medifast Inc	-8.92%	-26.58%	-62.96%	-92.05%	-80.93%
Frontdoor Inc	-29.6%	-12.18%	37.69%	48.53%	7.9%
H&r Block, Inc.	-4.06%	-17.83%	6.42%	115.79%	159.54%
Service Corporation International	1.87%	0.92%	4.79%	32.08%	59.65%
Bright Horizons Family Solutions Inc	6.94%	-7.46%	12.96%	2.34%	-5.86%
Rollins Inc.	7.19%	4.57%	17.41%	54.92%	106.15%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Medifast Inc	74.16	74.16	1.95	-0.43	0.01	0.03	NA	19.71
Frontdoor Inc	13.53	13.53	NA	3.08	1.25	0.13	NA	3.17
H&r Block, Inc.	14.67	14.67	0.82	5.28	0.98	0.17	0.03	-6.52
Service Corporation International	22.68	22.68	1.73	3.84	0.32	0.03	0.02	11.6
Bright Horizons Family Solutions Inc	53.39	53.39	1.76	4.07	0.11	0.05	NA	22.27
Rollins Inc.	54.8	54.8	4.0	1.1	0.38	0.15	0.01	2.75

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Medifast Inc	Sell	$154.1M	-80.93%	74.16	0.35%
Frontdoor Inc	Buy	$3.1B	7.9%	13.53	12.75%
H&r Block, Inc.	Buy	$7.0B	159.54%	14.67	14.71%
Service Corporation International	Buy	$11.4B	59.65%	22.68	12.39%
Bright Horizons Family Solutions Inc	Buy	$7.4B	-5.86%	53.39	5.22%
Rollins Inc.	Buy	$25.5B	106.15%	54.8	13.76%

About Medifast

Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address obesity and support a healthy life in the United States. The company offers weight loss and weight management plans; and GLP-1 support plans that provide access to GLP-1 medications where clinically appropriate under the OPTAVIA brand name. It also provides bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups, as well as provides coaching support along with community, nutrition, and healthy habits, and helps people in their weight loss journey. It markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.

Organization	Medifast
Employees	504
CEO	Mr. Daniel R. Chard
Industry	Retail Trade

Management People of Medifast

Name	Title
Mr. Daniel R. Chard	Executive Chairman & CEO
Mr. James P. Maloney CPA	Chief Financial Officer
Mr. Anthony E. Tyree	Chief Business Operations Officer
Mr. Jason L. Groves Esq.	Executive VP, General Counsel & Corporate Secretary
Mr. Nicholas M. Johnson	Chief Field Operations Officer
Mr. Jonathan Barrett MacKenzie	VP of Finance & Chief Accounting Officer
Mr. Steven Zenker	Vice President of Investor Relations
Ms. Claudia C. Greninger	Chief Human Resources Officer

Important FAQs about investing in MED Stock from India :

What is Medifast share price today?

Medifast share price today stands at $14.09, Open: $14.23 ; Previous Close: $14.23 ; High: $14.40 ; Low: $14.08 ; 52 Week High: $40.32 ; 52 Week Low: $13.57.

The stock opens at $14.23, after a previous close of $14.23. The stock reached a daily high of $14.40 and a low of $14.08, with a 52-week high of $40.32 and a 52-week low of $13.57.

Can Indians buy Medifast shares?

Yes, Indians can invest in the Medifast (MED) from India.

With INDmoney, you can buy Medifast at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Medifast at zero transaction cost.

How can I buy Medifast shares from India?

It is very easy to buy Medifast from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Medifast (MED) be purchased?

Yes, you can buy fractional shares of Medifast with INDmoney app.

What are the documents required to start investing in Medifast stocks?

To start investing in Medifast, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.